<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY UNAUDITED FINANCIAL INFORMATION EXTRACTED FROM
NOVEN PHARMACEUTICALS, INC. FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 18,798
<SECURITIES> 0
<RECEIVABLES> 4,480
<ALLOWANCES> 156
<INVENTORY> 5,315
<CURRENT-ASSETS> 32,123
<PP&E> 21,882
<DEPRECIATION> 6,696
<TOTAL-ASSETS> 64,165
<CURRENT-LIABILITIES> 9,341
<BONDS> 0
0
0
<COMMON> 2
<OTHER-SE> 69,162
<TOTAL-LIABILITY-AND-EQUITY> 64,165
<SALES> 19,791
<TOTAL-REVENUES> 20,084
<CGS> 9,023
<TOTAL-COSTS> 18,792
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 467
<INCOME-PRETAX> 5,489
<INCOME-TAX> 188
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 5,301
<EPS-BASIC> .24
<EPS-DILUTED> .23
</TABLE>